Abstract
Vulvar skin complaints represent a significant proportion of visits to family physician, dermatology and gynecology offices. Healthcare training programs place little emphasis on exposure to these conditions, which limits providers’ ability to assess and manage them. Increasing the visibility, recognition, and treatment of these conditions serves to improve patient care in Canada.
Reference17 articles.
1. Goldstein AT, Marinoff SC, Christopher K, et al. Prevalence of vulvar lichen sclerosus in a general gynecology practice. J Reprod Med. 2005;50(7):477-80.
2. Deo MS, Kerse N, Vandal AC, et al. Dermatological disease in the older age group: a crosssectional study in aged care facilities. BMJ Open. 2015;5(12):e009941.
3. Kreuter A, Kryvosheyeva Y, Terras S, et al. Association of autoimmune diseases with lichen sclerosus in 532 male and female patients. Acta Derm Venereol. 2013;93(2):238-41.
4. Krapf JM, Mitchell L, Holton MA, et al. Vulvar lichen sclerosus: current perspectives. Int J Womens Health. 2020;12:11-20.
5. Krapf JM, Smith AB, Cigna ST, Goldstein AT. Presenting Symptoms and Diagnosis of Vulvar Lichen Sclerosus in Premenopausal Women: A Cross-Sectional Study. J Low Genit Tract Dis. 2022;26(3):271-5.